Angiogenesis in pterygium: Morphometric and immunohistochemical study

Current Eye Research

Volumn 25, Issue 1, 2002, Pages 17-22

  Marcovich, Arie L ^a   Morad, Yair ^c   Sandbank, Judith ^c   Huszar, Monica ^a,b   Rosner, Mordechai ^d   Pollack, Ayala ^a   Herbert, Mehrdad ^c   Bar Dayan, Yaron ^d  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c ASSAF HAROFEH MEDICAL CENTER   (Israel)

^d NONE

Author keywords

Angiogenesis; Immunohistochemical; Pterygium; Vascular endothelial growth factor; VEGF

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DENSITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTERYGIUM; STROMA CELL; VASCULAR ENDOTHELIUM;

ADULT; AGED; CONJUNCTIVA; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PTERYGIUM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0036962772     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.25.1.17.9959     Document Type: Article

References (31)

1. Hill JC, Maske R. Pathogenesis of pterygium. Eye. 1989;3:218-226.
2. Wong WW. A hypothesis on the pathogenesis of pterygiums. Ann of Ophthalmol. 1978;10:303-308.
3. Coroneo MT, Di Girolamo N, Wakefield D. The pathogenesis of pterygia. Curr Opin Ophthalmol. 1999;10:282-288.
4. Powers MR, Qu Z, O'Brien B et al. Immunolocalization of bFGF in pterygia: Association with mast cells. Cornea. 1997;16:545-549.
5. Nagakami T, Murakami A, Okisaka S et al. Mast cells in pterygium: Number and phenotype. Jpn J Ophthalmol. 1999;43:75-79.
6. Kria L, Ohira A, Amemiya T. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor and tumor necrosis factor α in the pterygium. Acta Histochem. 1996;98:195-201.
7. Kria L, Ohira A, Amemiya T. Growth factors in cultured pterygium fibroblasts: Immunohistochemical and ELISA analysis. Graefe's Arch Clin Exp Ophthalmol. 1998;236:702-708.
8. Taylor HR. Aetiology of climatic droplet keratopathy and pterygium. Br J Ophthalmol. 1980;64:154-163.
9. Moran DJ, Hollows FC. Pterygium and ultraviolet radiation: A positive correlation. Br J Ophthalmol. 1984;68:343-346.
10. Karai I, Horiguchi S. Pterygium in welders. Br J Ophthalmol. 1984;68:347-349.
11. Leung DW, Cachianes G, Kuang WJ et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science. 1989;246:1306-1309.
12. Junquera F, Saperas E, de Torres I et al. Increased expression of angiogenic factors in human colonic angiodysplasia. Am J Gastroenterol. 1999;94:1070-1076.
13. Kim I, Ryan AM, Rohan R et al. Constitutive expression of VEGF, VEGFR-1 and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci. 1999;40:2115-2121.
14. Amano S, Rohan R, Kuroki M et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
15. Turley H, Scott PAE, Watts MW et al. Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1. J Pathol. 1998;186:313-318.
16. Folkman J. Clinical applications of research on angiogenesis. N Eng J Med. 1995;333:1757-1763.
17. Davidson B, Goldberg I, Kopolovic J. Angiogenesis in uterine cervical intraepithelial neoplasia and squamous cell carcinoma: An immunohistochemical study. Int J Gynecol Pathol. 1997;16:335-338.
18. Terayama N, Terada T, Nakanuma Y. A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver. Hepathology. 1996;24:816-819.
19. Siitonen SM, Haapasalo HK, Rantala IS et al. Comparison of different immunohistochemical methods in the assesment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas. Modern Pathology. 1995;8:745-752.
20. Peled A, Grabovsky V, Habler L et al. The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow. J Clin Invest. 1999;104:1199-1211.
21. Seifert P, Sekundo W. Capillaries in the epithelium of pterygium. Br J Ophthalmol. 1998;82:77-81.
22. Steuhl KP. Ultrastructure of the conjunctival epithelium. In: Straub W, ed. Developments in Ophthalmology. Basel: Karger; 1989:1-99.
23. Di Girolamo N, McCluskey P, Lloyd A et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671-679.
24. Edelman JL, Castro MR, Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci. 1999;40:1112-1123.
25. Philipp W, Speicher L, Humpel C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci. 2000;41:2514-2522.
26. Lee DH, Cho HJ, Kim JT, Choi JS, Joo CK. Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea. 2001;20:738-742.
27. Van Setten GB. Vascular endothelial growth factor (VEGF) in normal human corneal epithelium: Detection and physiological importance. Acta Ophthalmol Scand. 1997;75:649-652.
28. Hui-Kang Ma D, Jui-Fang Tsai R, Chu WK et al. Inhibition of vascular endothelial cell morphogenesis in cultures by limbal epithelial cells. Invest Ophthalmol Vis Sci. 1999;40:1822-1828.
29. Kria L, Ohira A, Amemiya T. TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: A possible drug therapy for pterygia. Curr Eye Res. 1998;17:986-993.
30. Kim KJ, Bing L, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis supresses tumour growth in vivo. Nature. 1993;362:841-844.
31. Yatoh S, Kawakami Y, Imai M et al. Effect of a topically applied neutralizing antibody against vascular endothelial growth factor on corneal allograft rejection of rat. Transplantation. 1998;66:1519-1524.